Metlife Inc (MET)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Total Investments | 472,178,000 | 441,364,000 | 446,137,000 | 433,293,000 | 494,821,000 |
| Cash & Cash Equivalents | 22,032,000 | 20,068,000 | 20,639,000 | 20,195,000 | 20,047,000 |
| Equity Investments | 858,000 | 712,000 | 757,000 | 1,684,000 | 1,269,000 |
| Accrued Investment Income | 3,719,000 | 3,489,000 | 3,589,000 | 3,446,000 | 3,185,000 |
| Premiums Receivable | 49,059,000 | 29,761,000 | 28,971,000 | 17,364,000 | 17,149,000 |
| Deferred Policy Acquisition Costs | 21,107,000 | 19,627,000 | 20,151,000 | 19,653,000 | 16,061,000 |
| Deferred Assets | 2,585,000 | 2,994,000 | 2,612,000 | 2,439,000 | 189,000 |
| Intangibles | 9,613,000 | 8,901,000 | 9,236,000 | 9,297,000 | 9,535,000 |
| Separate Account Assets | 151,933,000 | 139,504,000 | 144,634,000 | 146,038,000 | 179,873,000 |
| Other assets | 713,521,000 | 648,488,000 | 657,709,000 | 633,580,000 | 730,126,000 |
| Total Assets | $745,166,000 | $677,457,000 | $687,584,000 | $663,072,000 | $759,708,000 |
| Liabilities | |||||
| Future Policy Benefits | 231,687,000 | 215,511,000 | 219,707,000 | 209,796,000 | 219,632,000 |
| Policyholder Funds | 236,857,000 | 221,445,000 | 219,269,000 | 210,597,000 | 203,473,000 |
| Long Term Debt | 14,819,000 | 15,562,000 | 16,185,000 | 15,363,000 | 14,699,000 |
| Separate Account Liabilities | 151,933,000 | 139,504,000 | 144,634,000 | 146,038,000 | 179,873,000 |
| Other liabilities | 701,667,000 | 634,192,000 | 641,146,000 | 617,584,000 | 677,260,000 |
| Total Liabilities | $716,486,000 | $649,754,000 | $657,331,000 | $632,947,000 | $691,959,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 652,054 | 681,228 | 723,020 | 774,362 | 825,078 |
| Common Shares | 12,000 | 12,000 | 12,000 | 12,000 | 12,000 |
| Additional Paid Capital | 32,858,000 | 33,791,000 | 33,690,000 | 33,616,000 | 33,511,000 |
| Retained earnings | 44,290,000 | 42,626,000 | 40,146,000 | 40,332,000 | 41,197,000 |
| Treasury Shares | 30,678,000 | 27,798,000 | 24,591,000 | 21,458,000 | 18,157,000 |
| Other shareholders' equity | -17,802,000 | -20,928,000 | -19,004,000 | -22,377,000 | 11,186,000 |
| TOTAL | $28,680,000 | $27,703,000 | $30,253,000 | $30,125,000 | $67,749,000 |
| Total Liabilities And Equity | $745,166,000 | $677,457,000 | $687,584,000 | $663,072,000 | $759,708,000 |